Author: Aukrust Pål Yndestad Arne Smith Camilla Sandberg Wiggo J Ueland Thor Wæhre Torgun Halvorsen Bente Gullestad Lars Damås Jan Kristian
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.6, Iss.13, 2005-10, pp. : 2169-2180
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability
Current Drug Targets, Vol. 16, Iss. 4, 2015-04 ,pp. :
Potential Use of Dendritic Cells for Anti-Atherosclerotic Therapy
Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. :
The vulnerable atherosclerotic plaque
Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. :
Agents that stabilise atherosclerotic plaque
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 10, 2003-10 ,pp. :